Trial

For months, President Trump has promoted hydroxychloroquine as a potential treatment for covid-19, calling the anti-malarial drug a “game changer”; asking patients, “What do you have to lose?” — and even announcing that he was taking the drug in an attempt to ward off the novel coronavirus.On Monday, however, the World Health Organization announced it…

The World Health Organization said Monday it had temporarily suspended clinical trials of hydroxychloriquine as a potential treatment for COVID-19 being carried out across a range of countries as a precautionary measure.The decision came after publication last week of a study in The Lancet which indicated that using the drug on COVID-19 patients could increase…

Last Updated May 15, 2020 7:06 PM EDT The director of the National Institutes of Health (NIH) has said that no corners will be cut in the search for a coronavirus vaccine. But now, there's encouraging news about a potential vaccine that's now being tested on humans and monkeys. NIH researchers in Montana tested the vaccine…

Northwell Health CEO Michael Dowling said that scientists working on a drug trial for famotidine, a common heartburn medication, have "a reasonable confidence" that the drug may make a difference in the treatment of Covid-19 patients. "It's one of many trials we're doing, but we believe in the next two weeks or so we'll have some…

Published: April 27, 2020 at 2:35 a.m. ET A trial in a New York hospital is testing the heartburn medication Pepcid as a treatment for COVID-19, according to a report in Science. Pepcid, a generic drug marketed by Merck MRK, +0.68% and Johnson & Johnson JNJ, -0.41%, is being tested on 187 COVID-19 patients in…